Similar approaches using genetically modified astrocytes overexpressing BDNF or Nrf2 have proven beneficial in models of neurodegenerative diseases where astrocytosis is a hallmark of disease progression [36]–[38]. Here, BDNF is linked to neurodegenerative disease.